<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/61D20CC7-787C-455B-936A-3E16D0122205"><gtr:id>61D20CC7-787C-455B-936A-3E16D0122205</gtr:id><gtr:name>Semmelweis University</gtr:name><gtr:address><gtr:line1>Semmelweis University</gtr:line1><gtr:line2>Alkotas u. 44</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Dept of Medicine</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/61D20CC7-787C-455B-936A-3E16D0122205"><gtr:id>61D20CC7-787C-455B-936A-3E16D0122205</gtr:id><gtr:name>Semmelweis University</gtr:name><gtr:address><gtr:line1>Semmelweis University</gtr:line1><gtr:line2>Alkotas u. 44</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D62336DA-A6C2-47B2-9271-B9CC40FCB1A8"><gtr:id>D62336DA-A6C2-47B2-9271-B9CC40FCB1A8</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Edwards</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D408CDCF-A1AA-4F5C-BB80-FD3F407730FF"><gtr:id>D408CDCF-A1AA-4F5C-BB80-FD3F407730FF</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:surname>Whitelaw</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/02E446DE-298E-4426-8FAF-CA965B79597F"><gtr:id>02E446DE-298E-4426-8FAF-CA965B79597F</gtr:id><gtr:firstName>Henry</gtr:firstName><gtr:surname>Halliday</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8F4191DC-98B5-4C58-89B3-8C4C67CBBFC2"><gtr:id>8F4191DC-98B5-4C58-89B3-8C4C67CBBFC2</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>Brocklehurst</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/450CFB31-01DB-46BE-B72C-9DF587435B4A"><gtr:id>450CFB31-01DB-46BE-B72C-9DF587435B4A</gtr:id><gtr:firstName>Marianne</gtr:firstName><gtr:surname>Thoresen</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/0D2BBCEB-10B8-46FA-B802-EABCCA945073"><gtr:id>0D2BBCEB-10B8-46FA-B802-EABCCA945073</gtr:id><gtr:firstName>Malcolm</gtr:firstName><gtr:otherNames>Irvin</gtr:otherNames><gtr:surname>Levene</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D9D97ED2-8161-4E15-BF23-7156FBF5BC7E"><gtr:id>D9D97ED2-8161-4E15-BF23-7156FBF5BC7E</gtr:id><gtr:firstName>Denis</gtr:firstName><gtr:otherNames>V</gtr:otherNames><gtr:surname>Azzopardi</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0100126"><gtr:id>A7383307-57A0-4992-BAFE-7627B8BBAD7C</gtr:id><gtr:title>Whole Body Hypothermia for the Treatment of Perinatal Asphyxial Encephalopathy (TOBY)</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0100126</gtr:grantReference><gtr:abstractText>Although major advances have been made in the care of mothers and babies, approximately 2 out of every 1000 newborn infants suffer from a lack of oxygen (asphyxia) around the time of birth that may cause death or injury to the brain. Currently there are no specific treatments that reduce the risk of death or brain injury following asphyxia. However, many possible treatments have been suggested as a result of experimental work. Of these, mild body cooling (hypothermia) has most consistently shown benefit, and preliminary small studies in babies have been promising. 

This proposed randomized trial aims to find out whether mild cooling of babies suffering moderate and severe asphyxia prevents babies from dying or developing later disability (which will be measured when the children are 18 moths of age). To do this, babies who are thought to have suffered asphyxia will be assessed within 6 hours of birth and babies with moderate or severe asphyxia will be randomly selected so that in half the rectal temperature is kept at a normal level (37oC) and in the other half the temperature is kept at 33.5-34 oC for 72 hours, after which it will slowly be returned to normal. All other care in the two groups will be according to current clinical practice. In order to demonstrate a 30% reduction in death and disability with cooling treatment, 236 babies will need to be enrolled into the trial. Information will be collected from the babies at the time of the trial entry, during the first 80 hours after trial entry, when they are discharged from the neonatal unit (or die) and when they are aged 18 months.</gtr:abstractText><gtr:technicalSummary>This proposal is for a pragmatic, multicentre, randomized trial to investigate whether a reduction of body temperature by 3-4oC in full term infants with perinatal asphyxial encephalopathy is a safe treatment that may improve survival without neurodevelopmental impairments.

Moderate or severe perinatal asphyxial encephalopathy occurs in approximately 2/1000 births and is associated with an increasing risk of death or neurodevelopmental impairments with more severe encephalopathy: approximately 25% of infants who suffer moderate asphyxial encephalopathy will develop cerebral palsy, whilst almost all infants with severe asphyxial encephalopathy die or survive with multiple handicaps. Perinatal asphyxia may account for up to 30% of cases of cerebral palsy and is a very significant health care and financial burden to the NHS. 

236 infants with clinical and EEG evidence of asphyxial encephalopathy will be randomized within 6 hours of birth to either a control group with the rectal temperature kept at 37 +/- 0.2oC or to whole body cooling when the rectal temperature will be kept at 33.5 +/- 0.5oC for 72 hours followed by slow rewarming. The primary outcome measure is the combined rate of mortality and severe neurodevelopmental impairments in survivors at 18 months of age. Secondary outcome measures include the occurrence of adverse effects. An intention to treat analysis will be performed and predefined subgroup analysis will be based on the severity of encephalopathy assessed by amplitude integrated EEG.</gtr:technicalSummary><gtr:fund><gtr:end>2009-01-01</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2002-09-02</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>720421</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>National Perinatal Epidemiology Unit Oxford</gtr:department><gtr:description>TOBY UK Cooling Regster</gtr:description><gtr:id>FF10A853-AE0E-47F0-8CCC-9CC65D9B0AE5</gtr:id><gtr:impact>Publications</gtr:impact><gtr:outcomeId>AUbeAXRHFkT-1</gtr:outcomeId><gtr:partnerContribution>Publications and set up of research network</gtr:partnerContribution><gtr:piContribution>Clinical Lead for national registry of infants treated with cooling in the Uk</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Semmelweiss University</gtr:collaboratingOrganisation><gtr:country>Hungary, Republic of</gtr:country><gtr:description>Semmelweiss Unversity</gtr:description><gtr:id>F2CBC20B-10C3-4602-8128-1FF7C7A186B0</gtr:id><gtr:impact>Pubications</gtr:impact><gtr:outcomeId>ED96DF67A51-1</gtr:outcomeId><gtr:partnerContribution>Enabled secondary studies related to main trial</gtr:partnerContribution><gtr:piContribution>Helped set up and anlyse substudy</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Experimental Medicine Call II</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>03A5B126-52A7-412A-8700-209E20A391F3</gtr:id><gtr:outcomeId>E9F12F266DC0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>965951</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Programme Grant</gtr:description><gtr:end>2014-05-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0801320</gtr:fundingRef><gtr:id>6009966E-4403-4E98-8BF8-2AB839D50F50</gtr:id><gtr:outcomeId>58c7cf4fb702f3.73587194</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NAAT 2011 Reported_Membership Guideline</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DC6815C1-1B16-4F7D-9B85-A4417FB36F57</gtr:id><gtr:impact>BAPM guidelines for neural rescue therapy in newborn</gtr:impact><gtr:outcomeId>52782203061cd</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NAAT 2011 reported_BMJ or Lancet Citation</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>48EF8FA4-8DD5-4424-82FD-B90248AA45A7</gtr:id><gtr:impact>New therapy which doubles chance of normal survival and reduces total societal health costs</gtr:impact><gtr:outcomeId>5278222d1103b</gtr:outcomeId><gtr:type>Citation in systematic reviews</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>National Institute of Health, USA</gtr:description><gtr:geographicReach>North America</gtr:geographicReach><gtr:id>A3D1B874-1B04-4420-BBBD-32CBDDA1F7DC</gtr:id><gtr:impact>NIH workshops to formulate guidelines for: (i) therapeutic hypothermia, (ii) perinatal stroke, and (iii) neonatal hypoglycaemia.

Influential in US practice and research agenda</gtr:impact><gtr:outcomeId>mZipxASV78Y</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Endorsement of hypothermia therapy by NICE and BAPM</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>650EAD29-363A-48AA-AC69-F029D0009485</gtr:id><gtr:impact>Endorsement has increased uptake of therapeutic hypothermia</gtr:impact><gtr:outcomeId>6426800BB02</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NICE guideline</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:guidelineTitle>IPG347 Therapeutic hypothermia with intracorporeal temperature monitoring for hypoxic perinatal brain injury</gtr:guidelineTitle><gtr:id>CA58EC76-519F-49CE-AD50-A5C101C79ED8</gtr:id><gtr:impact>Our work on hypothermia has been the subject of a review by NICE to which we contributed expert guidance. On 17-12-09 NICE held a public hearing and the preliminary guidance is that the treatment should become part of normal NHS practice. In March 2010 formal guidance was published stating that hypothermia should become standard of care. The British Association of Perinatal Medicine simultaneously issued guidelines for the general application of the therapy across the UK.</gtr:impact><gtr:outcomeId>7B2D03E4606</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type><gtr:url>http://www.nice.org.uk/ipg347</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>This was a clinical trial of therapeutic hypothermia after perinatal asphyxia: ISRCTN89547571
This therapy is now standard care</gtr:description><gtr:id>F9C24B06-7884-4144-A232-98B13F87B7F1</gtr:id><gtr:impact>As a result of this trial therapeutic hypothermia following perinatal asphyxia was endorsed by NICE and is now standard therapy</gtr:impact><gtr:outcomeId>Vizp79EXNUt</gtr:outcomeId><gtr:stage>Wide-scale adoption</gtr:stage><gtr:status>Closed</gtr:status><gtr:title>Toby Trial</gtr:title><gtr:type>Therapeutic Intervention - Physical</gtr:type><gtr:url>http://www.npeu.ox.ac.uk/toby</gtr:url><gtr:yearDevCompleted>2012</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>National registry of treatment with cooling hor neonatal encephalopathy</gtr:description><gtr:id>D7B92F26-0A7B-4606-9A3E-51016C9F654F</gtr:id><gtr:impact>National register of clinical use of therapeutic hypothermia in neonates</gtr:impact><gtr:outcomeId>B9336DF35A0</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>UK TOBY cooling registry</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>C96927D4-83D0-4D82-8397-07CBF9D674D0</gtr:id><gtr:title>Therapeutic hypothermia following perinatal asphyxia.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood. Fetal and neonatal edition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9454813b938eb300fd66d55c657bbbe"><gtr:id>b9454813b938eb300fd66d55c657bbbe</gtr:id><gtr:otherNames>Edwards AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1359-2998</gtr:issn><gtr:outcomeId>3CF5FF410B6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1D50DDB-3CE2-42E0-A31F-22CF8C27C3A8</gtr:id><gtr:title>Treatment of asphyxiated newborns with moderate hypothermia in routine clinical practice: how cooling is managed in the UK outside a clinical trial.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood. Fetal and neonatal edition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7b71591412aa3c7ac05af8226565c7d"><gtr:id>c7b71591412aa3c7ac05af8226565c7d</gtr:id><gtr:otherNames>Azzopardi D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1359-2998</gtr:issn><gtr:outcomeId>0C83BC15DC2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB34BC1F-A0AB-4BF9-AA18-943F711AFA91</gtr:id><gtr:title>Predictive value of the amplitude integrated EEG in infants with hypoxic ischaemic encephalopathy: data from a randomised trial of therapeutic hypothermia.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood. Fetal and neonatal edition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7b71591412aa3c7ac05af8226565c7d"><gtr:id>c7b71591412aa3c7ac05af8226565c7d</gtr:id><gtr:otherNames>Azzopardi D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1359-2998</gtr:issn><gtr:outcomeId>pm_14163_23_23800393</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4DE2D7EC-4AAE-449B-9780-C28034CE192A</gtr:id><gtr:title>Lack of influence of mild hypothermia on amplitude integrated-electroencephalography in neonates receiving extracorporeal membrane oxygenation.</gtr:title><gtr:parentPublicationTitle>Early human development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d4f46206156a8fc106a8000c1cf313d"><gtr:id>0d4f46206156a8fc106a8000c1cf313d</gtr:id><gtr:otherNames>Horan M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0378-3782</gtr:issn><gtr:outcomeId>76197835DB0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABEE60D1-6BCA-4150-A8AC-ED7ADBFC0640</gtr:id><gtr:title>The TOBY Study. Whole body hypothermia for the treatment of perinatal asphyxial encephalopathy: a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>BMC pediatrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7b71591412aa3c7ac05af8226565c7d"><gtr:id>c7b71591412aa3c7ac05af8226565c7d</gtr:id><gtr:otherNames>Azzopardi D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1471-2431</gtr:issn><gtr:outcomeId>BCDD1B4E693</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29BDC6BD-4E0F-46EB-B4E5-946B70A670C5</gtr:id><gtr:title>Cost-effectiveness of therapeutic hypothermia to treat neonatal encephalopathy.</gtr:title><gtr:parentPublicationTitle>Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d3f31e51d4a99c567051611dc6cd47e"><gtr:id>5d3f31e51d4a99c567051611dc6cd47e</gtr:id><gtr:otherNames>Regier DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1098-3015</gtr:issn><gtr:outcomeId>hKgjqX4epWS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>442E2338-A208-4A75-AE0F-79B7FBB9B027</gtr:id><gtr:title>Hypothermia and perinatal asphyxia: executive summary of the National Institute of Child Health and Human Development workshop.</gtr:title><gtr:parentPublicationTitle>The Journal of pediatrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/39e48dac3a039e56ab2de19f2c1b808f"><gtr:id>39e48dac3a039e56ab2de19f2c1b808f</gtr:id><gtr:otherNames>Higgins RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-3476</gtr:issn><gtr:outcomeId>1B5892DC22F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23CC9B8B-2AAD-4408-98FF-72D25D2D7BF0</gtr:id><gtr:title>Elevated morphine concentrations in neonates treated with morphine and prolonged hypothermia for hypoxic ischemic encephalopathy.</gtr:title><gtr:parentPublicationTitle>Pediatrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41a426d7e91b98ea313669508e8f6183"><gtr:id>41a426d7e91b98ea313669508e8f6183</gtr:id><gtr:otherNames>R?ka A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0031-4005</gtr:issn><gtr:outcomeId>3CB0933142A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEBD02A5-27DE-4A88-9FB9-D9EDADFBE242</gtr:id><gtr:title>Moderate hypothermia to treat perinatal asphyxial encephalopathy.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf5f3d7b6ef87e318bf60d530ca54968"><gtr:id>cf5f3d7b6ef87e318bf60d530ca54968</gtr:id><gtr:otherNames>Azzopardi DV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>D856DFA1F38</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A2A0C65-7DD1-4C9D-901F-2CEC3794D6BB</gtr:id><gtr:title>Therapeutic hypothermia for neonatal hypoxic ischaemic encephalopathy.</gtr:title><gtr:parentPublicationTitle>Early human development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7541f6a8f9142addf241db5b44f75358"><gtr:id>7541f6a8f9142addf241db5b44f75358</gtr:id><gtr:otherNames>Roka A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0378-3782</gtr:issn><gtr:outcomeId>pm_14163_23_20570448</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C49B5276-D8BA-4EEF-AD6B-84B60EFA986B</gtr:id><gtr:title>Hypothermia.</gtr:title><gtr:parentPublicationTitle>Seminars in fetal &amp; neonatal medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7b71591412aa3c7ac05af8226565c7d"><gtr:id>c7b71591412aa3c7ac05af8226565c7d</gtr:id><gtr:otherNames>Azzopardi D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1744-165X</gtr:issn><gtr:outcomeId>5EC54FD0443</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A613FF6-3C5A-428B-B78E-BDF0223DB159</gtr:id><gtr:title>Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9454813b938eb300fd66d55c657bbbe"><gtr:id>b9454813b938eb300fd66d55c657bbbe</gtr:id><gtr:otherNames>Edwards AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>dA3FSsfPt3a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>899ABB6E-5F52-4824-BED4-98A17D18CF78</gtr:id><gtr:title>Birth asphyxia: 100 years of progress.</gtr:title><gtr:parentPublicationTitle>The Journal of pediatrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/04f59b4e74e10c2c64c9b25a5075eb77"><gtr:id>04f59b4e74e10c2c64c9b25a5075eb77</gtr:id><gtr:otherNames>Tusor N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3476</gtr:issn><gtr:outcomeId>545b6ba677a2c4.30215250</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A75835EC-A848-42A2-BCAB-280D68031E98</gtr:id><gtr:title>Changes in serum cytokine and cortisol levels in normothermic and hypothermic term neonates after perinatal asphyxia.</gtr:title><gtr:parentPublicationTitle>Inflammation research : official journal of the European Histamine Research Society ... [et al.]</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41a426d7e91b98ea313669508e8f6183"><gtr:id>41a426d7e91b98ea313669508e8f6183</gtr:id><gtr:otherNames>R?ka A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1023-3830</gtr:issn><gtr:outcomeId>pm_14163_23_22986466</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D39A581-A929-4E03-947E-BD2228B5A75D</gtr:id><gtr:title>Serum S100B and neuron-specific enolase levels in normothermic and hypothermic infants after perinatal asphyxia.</gtr:title><gtr:parentPublicationTitle>Acta paediatrica (Oslo, Norway : 1992)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7541f6a8f9142addf241db5b44f75358"><gtr:id>7541f6a8f9142addf241db5b44f75358</gtr:id><gtr:otherNames>Roka A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0803-5253</gtr:issn><gtr:outcomeId>pm_14163_23_21981269</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA37C5EB-CA24-4FFD-BB63-CC9D7F4CBE84</gtr:id><gtr:title>Subcutaneous fat necrosis after moderate therapeutic hypothermia in neonates.</gtr:title><gtr:parentPublicationTitle>Pediatrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14c39727e4025fd706b23338a4961e13"><gtr:id>14c39727e4025fd706b23338a4961e13</gtr:id><gtr:otherNames>Strohm B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0031-4005</gtr:issn><gtr:outcomeId>pm_14163_23_21727110</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57A31BA6-A18C-4728-9251-BBB06DA31F94</gtr:id><gtr:title>Tract-based spatial statistics of magnetic resonance images to assess disease and treatment effects in perinatal asphyxial encephalopathy.</gtr:title><gtr:parentPublicationTitle>Pediatric research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c54a19f4348c091df5255a6c436f1175"><gtr:id>c54a19f4348c091df5255a6c436f1175</gtr:id><gtr:otherNames>Porter EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0031-3998</gtr:issn><gtr:outcomeId>Z4PQDWGNu9N</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE6F82E7-500C-4F54-99F1-E0C766530E03</gtr:id><gtr:title>Therapeutic hypothermia for neonatal encephalopathy: a UK survey of opinion, practice and neuro-investigation at the end of 2007.</gtr:title><gtr:parentPublicationTitle>Acta paediatrica (Oslo, Norway : 1992)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/413809cab67f8246cebb17889e08d5fc"><gtr:id>413809cab67f8246cebb17889e08d5fc</gtr:id><gtr:otherNames>Kapetanakis A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0803-5253</gtr:issn><gtr:outcomeId>E01B1F33B7B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>700AAA64-3E8E-4637-91E1-8E9ADE3729AF</gtr:id><gtr:title>Temperature control during therapeutic moderate whole-body hypothermia for neonatal encephalopathy.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood. Fetal and neonatal edition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14c39727e4025fd706b23338a4961e13"><gtr:id>14c39727e4025fd706b23338a4961e13</gtr:id><gtr:otherNames>Strohm B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1359-2998</gtr:issn><gtr:outcomeId>1A8B340A054</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>247F54F1-6445-443C-B7E7-E5CD65786623</gtr:id><gtr:title>Passive cooling for initiation of therapeutic hypothermia in neonatal encephalopathy.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood. Fetal and neonatal edition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8abfd8760f8fa11daa9eaf6e0ad3786"><gtr:id>b8abfd8760f8fa11daa9eaf6e0ad3786</gtr:id><gtr:otherNames>Kendall GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1359-2998</gtr:issn><gtr:outcomeId>pm_14163_23_20870910</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE4EB8A4-0340-4AF8-B971-D7B57115A763</gtr:id><gtr:title>Improving infant outcome with a 10 min Apgar of 0.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood. Fetal and neonatal edition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76354bc65fec37359883928acb8f93c4"><gtr:id>76354bc65fec37359883928acb8f93c4</gtr:id><gtr:otherNames>Kasdorf E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1359-2998</gtr:issn><gtr:outcomeId>5458d31e9d13e2.63745163</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>315C7E25-531A-4554-A10E-2A28BAA3FAFE</gtr:id><gtr:title>Assessment of brain tissue injury after moderate hypothermia in neonates with hypoxic-ischaemic encephalopathy: a nested substudy of a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e064932c84e9e138a83031707d66abe"><gtr:id>6e064932c84e9e138a83031707d66abe</gtr:id><gtr:otherNames>Rutherford M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>86CAFC3FE13</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2A25AFF-ADA3-480F-ADA2-5ED968DD44DF</gtr:id><gtr:title>Implementation and conduct of therapeutic hypothermia for perinatal asphyxial encephalopathy in the UK--analysis of national data.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7b71591412aa3c7ac05af8226565c7d"><gtr:id>c7b71591412aa3c7ac05af8226565c7d</gtr:id><gtr:otherNames>Azzopardi D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14163_23_22719897</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0100126</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>FA7AA693-7EDD-4A7E-8CA3-6B5658FBF717</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Reproductive Health and Childbirth</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>74DC189C-F240-42D1-84DD-85475A95ABE8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>6.7  Physical</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>